Menu
GeneBe

POMK

protein O-mannose kinase

Basic information

Region (hg38): 8:43093497-43131180

Links

ENSG00000185900NCBI:84197OMIM:615247HGNC:26267Uniprot:Q9H5K3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 (Strong), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 (Moderate), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy, type A (Supportive), mode of inheritance: AR
  • congenital muscular dystrophy with cerebellar involvement (Supportive), mode of inheritance: AR
  • limb-girdle muscular dystrophy due to POMK deficiency (Supportive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A, 12; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type C, 12; Muscle-eye brain disease; Walker-Warburg syndromeARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal; Neurologic; Ophthalmologic23519211; 24556084; 24925318

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the POMK gene.

  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency (111 variants)
  • Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 (90 variants)
  • not provided (61 variants)
  • Inborn genetic diseases (17 variants)
  • not specified (14 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 (10 variants)
  • Limb-girdle muscular dystrophy due to POMK deficiency (5 variants)
  • POMK-related condition (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the POMK gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
57
clinvar
2
clinvar
59
missense
119
clinvar
5
clinvar
124
nonsense
4
clinvar
2
clinvar
6
start loss
2
clinvar
2
frameshift
6
clinvar
4
clinvar
1
clinvar
11
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
4
1
5
non coding
8
clinvar
5
clinvar
13
Total 10 6 123 70 7

Highest pathogenic variant AF is 0.0000197

Variants in POMK

This is a list of pathogenic ClinVar variants found in the POMK region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-43093551-G-T Likely benign (Apr 09, 2018)387812
8-43097519-TAAAG-T not specified Benign (May 23, 2016)420190
8-43103230-T-G Likely benign (May 14, 2019)1186478
8-43103459-A-G Likely benign (Jul 21, 2018)1215652
8-43103549-A-G Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Uncertain significance (Feb 24, 2022)999804
8-43103551-G-C Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Uncertain significance (Oct 04, 2022)1047054
8-43103558-C-T Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Pathogenic/Likely pathogenic (Dec 22, 2022)849427
8-43103568-A-G Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Conflicting classifications of pathogenicity (Dec 06, 2023)432418
8-43103572-C-T Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Likely benign (Apr 21, 2022)1906472
8-43103576-A-G Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Uncertain significance (Oct 15, 2020)1009402
8-43103581-C-A Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Likely benign (Aug 03, 2023)1618648
8-43103581-C-G Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Likely benign (Dec 13, 2018)774261
8-43103584-C-T Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Likely benign (Aug 09, 2022)2140882
8-43103585-G-A Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Uncertain significance (Aug 07, 2023)1962085
8-43103585-G-GC Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Pathogenic/Likely pathogenic (Mar 18, 2022)817678
8-43103586-C-T Uncertain significance (Jun 26, 2020)1312754
8-43103587-C-G Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Likely benign (Sep 24, 2021)1637756
8-43103587-C-T Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Likely benign (Feb 28, 2022)1978216
8-43103591-C-G Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Uncertain significance (Jul 06, 2022)1376882
8-43103591-C-T Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Pathogenic (Nov 25, 2023)1076046
8-43103592-G-A Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency • Inborn genetic diseases Conflicting classifications of pathogenicity (Dec 27, 2023)705716
8-43103592-G-T Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency • Inborn genetic diseases Uncertain significance (Apr 11, 2023)2190123
8-43103593-A-G Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 Likely benign (Jul 06, 2022)1116908
8-43103594-G-A Limb-girdle muscular dystrophy due to POMK deficiency;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 • Inborn genetic diseases Uncertain significance (Jun 19, 2022)1502572
8-43103595-A-G Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12;Limb-girdle muscular dystrophy due to POMK deficiency Uncertain significance (Aug 15, 2022)851474

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
POMKprotein_codingprotein_codingENST00000331373 229920
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.95e-80.1391256820661257480.000262
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4691781960.9060.00001042310
Missense in Polyphen4259.5720.70503724
Synonymous-0.4218883.11.060.00000499690
Loss of Function0.07251212.30.9787.59e-7122

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002710.000271
Ashkenazi Jewish0.000.00
East Asian0.0002170.000217
Finnish0.0006930.000693
European (Non-Finnish)0.0003170.000316
Middle Eastern0.0002170.000217
South Asian0.00009800.0000980
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Protein O-mannose kinase that specifically mediates phosphorylation at the 6-position of an O-mannose of the trisaccharide (N-acetylgalactosamine (GalNAc)-beta-1,3-N- acetylglucosamine (GlcNAc)-beta-1,4-mannose) to generate phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine- beta-1,3-N-acetylglucosamine-beta-1,4-(phosphate-6-)mannose). Phosphorylated O-mannosyl trisaccharide is a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular proteins with high affinity. Only shows kinase activity when the GalNAc-beta-3-GlcNAc-beta-terminus is linked to the 4-position of O-mannose, suggesting that this disaccharide serves as the substrate recognition motif. {ECO:0000269|PubMed:23519211, ECO:0000269|PubMed:23929950}.;
Disease
DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C12 (MDDGC12) [MIM:616094]: An autosomal recessive limb-girdle congenital muscular dystrophy, characterized by muscle weakness and delayed motor development in association with cognitive impairment. {ECO:0000269|PubMed:24925318}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Mannose type O-glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;O-linked glycosylation (Consensus)

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.174
ghis
0.575

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pomk
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype;

Zebrafish Information Network

Gene name
pomk
Affected structure
muscle
Phenotype tag
abnormal
Phenotype quality
dystrophic

Gene ontology

Biological process
neuron migration;protein phosphorylation;protein O-linked glycosylation;brain development;learning or memory;sensory perception of pain;carbohydrate phosphorylation;neuromuscular process
Cellular component
endoplasmic reticulum membrane;integral component of membrane
Molecular function
protein kinase activity;ATP binding;phosphotransferase activity, alcohol group as acceptor;carbohydrate kinase activity